Bandhan Bank has sold its bad loans portfolio worth Rs 6,872 crore to asset restructuring companies, aiming to reduce its non-performing assets and improve its financial health.
Lupin signs licensing, supply, and distribution deal with China-based Gan & Lee Pharmaceuticals for a novel obesity and diabetes medication, strengthening its diabetes portfolio and accelerating its presence in the obesity segment.
Gold and silver prices experienced a significant drop as traders booked profits following a powerful year-end rally. Find out what this means for Indian investors and how to navigate the market.
The Union government plans to borrow Rs 3.84 lakh crore from short-term treasury bills in Q4 to meet short-term funding requirements. What does this mean for Indian investors and the economy?
Oil prices held gains as traders weighed geopolitical tensions from Venezuela to Russia and Iran against concerns about a glut, with West Texas Intermediate trading near $58 a barrel and Brent settling below $62.
Asian stocks are poised for a muted open following technology-led declines on Wall Street. What does this mean for Indian investors and the domestic market?
The Defence Acquisition Council’s approval for defence procurement deals worth Rs 79,000 crore has sent defence stocks soaring. Here are five defence stocks to keep an eye on, including Bharat Electronics Limited and Zen Technologies.
The Indian stock market ended the last trading day of the year on a negative note, with the NSE Nifty falling 100.2 points to 25,942.1 and the BSE Sensex declining 345.91 points to 84,695.54.
Get the latest updates on key stocks, including IndiGo, Bandhan Bank, and Indian Bank, and understand their impact on the Indian stock market.
Get the latest updates on Lenskart, Titan, Dixon Technologies, and other top stocks from global and domestic brokerages, along with their outlook on various sectors.